Sign In  |  Register  |  About Pleasanton  |  Contact Us

Pleasanton, CA
September 01, 2020 1:32pm
7-Day Forecast | Traffic

  • Search Hotels in Pleasanton

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Psilocybin program

Recent news which mentions Psilocybin program

< Previous 1 2 Next >
Compass' Psilocybin Therapy Proves Helpful In Treating Anorexia: Clinical Trial Shows
Tickers CMPS
Tags Market News Cannabis Psychedelic/Assisted Therapies
From Benzinga
Cybin, Bright Minds And PharmAla: A Short Recap On Progress Within Clinical Trials
Tickers CYBN DRUG PMBHF
Tags DRUG Psychedelics 5HT2C Receptor
From Benzinga
Filament Health Uplisting To NASDAQ In A $210M SPAC Deal
Tickers FLHLF JAQC
Tags Contracts Psychedelics Market News
From Benzinga
Compatibility Of Psilocybin & SSRIs For Depression, COMPASS Looks At 'Psychedelic-Assisted Therapies'
Tickers CMPS
Tags Small Cap treatment/resistant depression Psychedelics
From Benzinga
Filament Supplies Botanical Psilocybin To Canadian Researchers, Inks Global Licensing Deal
Tickers FLHLF
Tags News eating disorders Psychedelics
From Benzinga
Wesana Shareholders Vote For Psilocybin And CBD Therapy Asset Sales To Lucy Scientific
Tickers LSDI WSNAF
Tags Contracts Psychedelics Cannabis
From Benzinga
From The U.S. To Canada: High-Quality Psilocybin API Gets Green Light For Import
Tags Psychedelic/Assisted Therapies Global Benzinga
From Benzinga
Creso Pharma's LOI For Import Of Swiss MDMA And Psilocybin Therapeutics To Australia
Tickers COPHF MNMD
Tags Markets News MNMD
From Benzinga
Colorado Media Buzz On Psychedelic Mushroom Businesses, This Company Offers 'Top Rare' Strains
Tags News Psychedelics Psychedelics Colorado
From Benzinga
UCSF Clinical Trial Shows Promising Results For Naturally-Sourced Psilocybin And Psilocin
Tickers FLHLF
Tags University of California San Francisco Psilocin Clinical Trial Psychedelics
From Benzinga
Numinus' Clinical Site Joins Compass' Phase 3 Program On Psilocybin Therapy For TRD
Tickers CMPS NUMIF
Tags Psychedelics treatment/resistant depression Small Cap
From Benzinga
Washington State Psychedelics Trial Targets PTSD And Alcohol Use Disorder, Mandated By Law
Tags News Psychedelics Reform Psilocybin/Assisted Therapy
From Benzinga
Link Between Cancer And Psilocybin: Research On This Palliative Promise
Tickers CMPS
Tags CMPS Psychedelics Psychedelics Reform
From Benzinga
This Biotech Company Discovers What May Be The First New Compounds Of Psilocybin In History
Tags Markets Cannabis Market News
From Benzinga
EXCLUSIVE: Lessons From Psychedelics Markets Through Business, Legal And Reciprocity Lenses
Tickers BWVI
Tags Events Psychedelics Indigenous peoples
From Benzinga
COMPASS Pathways Reports Q1 2023: Financials, Commercial Groundwork And Ongoing Phase 3 Trials
Tickers CMPS
Tags Small Cap American Medical Association Psychedelics
From Benzinga
International IP Claims On Novel Psychedelic Fungi Biomass Manufacturing Gets Prelim Acceptance
Tags Cannabis Markets Market News
From Benzinga
Psyched: Canada's Case For Psilocybin Access And Microdose Trial, US Reform Update, Battle With DEA & More
Tickers IGXT NUMIF PHRRF RVVTF
Tags Markets RVVTF IGXT
From Benzinga
Therapists At Mass General Hospital Prepared To Assist IBS Patients With Psilocybin Therapy
Tickers TRYPF
Tags M&A Markets Irritable Bowel Syndrome
From Benzinga
Filament Health: 2022 Financials And Operational Highlights From Creator Of The Ayahuasca Pill
Tickers FLHLF JAGX
Tags Management News Earnings
From Benzinga
COMPASS Pathways: New Data & Insight On Psilocybin Therapy For Treatment-Resistant Depression
Tickers CMPS
Tags Interview Small Cap News
From Benzinga
Australia Receives First Batch Of Clinical-Grade Psilocybin From Mindset Pharma And PharmAla
Tickers MSSTF OPTHF
Tags OPTHF Australia Psychedelics Psychedelics
From Benzinga
COMPASS Pathways Shares Q4 & Year-End 2022 Financials, Advances Phase 3 Psilocybin Trials
Tickers CMPS
Tags Psychedelics CMPS News
From Benzinga
2C-B Vs. Psilocybin: New Study Shares Insightful Trial Results On The Mescaline-Derived Psychedelic's Effects
Tags General News Guidance
From Benzinga
State-Level Psychedelics In 2023: Oklahoma Introduces Research Bill, Washington Amends And Passes Measure
Tags Markets Guidance Politics
From Benzinga
Supply Partnerships: Filament's Psilocybin Trial In Canada, PharmAla's MDMA Program In Australia
Tickers FLHLF
Tags PharmAla Biotech Holdings Inc Legal Management
From Benzinga
Health Canada Grants Exemption: Phase 2 Trial On Psilocybin For Genetic Disorder
Tickers KONEF NMLSF
Tags NMLSF Markets Psilocybin Microdosing
From Benzinga
Psyched: 12 States Discuss Legalization Bills, Ceremonies For Veterans With TBI, Ketamine And MDMA Fast-Tracks & More
Tickers AWKNF NUMIF OPTHF PHRRF
Tags News SEEL Management
From Benzinga
Testing Psychedelics Efficacy On 'Psychiatry's Blind Spot': Latest King's College Trial
Tags King's College London Benzinga Psilocybin program
From Benzinga
How Do Psilocybin And MDMA Work Together? This Proposed Experiential Study Is Set To Find Out
Tickers OPTHF
Tags Psychedelics Health Canada OPTHF
From Benzinga
< Previous 1 2 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Photography by Christophe Tomatis
Copyright © 2010-2020 Pleasanton.com & California Media Partners, LLC. All rights reserved.